Safety and efficacy findings in the first-in-human trial (FIH) of the oral splice modulator branaplam in type 1 spinal muscular atrophy (SMA): interim results

Authors:
  • LCL. Charnas
    L. Charnas
  • EVE. Voltz
    E. Voltz
  • CPC. Pfister
    C. Pfister
  • TPT. Peters
    T. Peters
  • AHA. Hartmann
    A. Hartmann
  • CBC. Berghs-Clairmont
    C. Berghs-Clairmont
  • JPJ. Praestgaard
    J. Praestgaard
  • MRM. de Raspide
    M. de Raspide
  • NDN. Deconinck
    N. Deconinck
  • ABA. Born
    A. Born
  • GBG. Baranello
    G. Baranello
  • EBE. Bertini
    E. Bertini

Abstract
No abstract available